Paper Details
- Home
- Paper Details
Maternal morbidity associated with isoxsuprine and terbutaline tocolysis.
Author: CreasyR K, HerronM, KatzM, RobertsonP A
Original Abstract of the Article :
A retrospective study of 343 women treated with isoxsuprine and/or terbutaline for preterm labor (PTL) was performed to determine the incidence and nature of maternal morbidity which is associated with this treatment. The incidence of mild cardiovascular (CV), neurological and gastrointestinal side ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/0028-2243(81)90086-1
データ提供:米国国立医学図書館(NLM)
Tocolysis Medications: Evaluating Safety and Effectiveness
This research delves into the complexities of preterm labor, examining the safety and efficacy of two commonly used tocolytic medications: isoxsuprine and terbutaline. It's like comparing two different paths through a desert landscape, seeking to determine the safest and most effective route to prevent premature birth.Comparing Isoxsuprine and Terbutaline: Navigating the Risks and Benefits
This study compares the incidence and nature of maternal morbidity associated with isoxsuprine and terbutaline, aiming to identify potential risks and benefits. It's like carefully assessing the potential hazards and rewards of traversing different desert trails. The research found that both medications had similar success in inhibiting preterm labor, but terbutaline was associated with a higher incidence of severe cardiovascular complications, especially in patients with multiple gestations.Navigating the Uncertain Terrain of Preterm Labor
Preterm labor is a significant challenge for both mothers and their babies. This study provides valuable insights into the safety and efficacy of tocolytic medications, offering guidance for healthcare providers in making informed decisions about treatment strategies. It's like having a map to guide us through the often-unpredictable terrain of preterm labor, helping us to find the safest and most effective path for mothers and their babies.Dr. Camel's Conclusion
This research navigates the complex landscape of preterm labor, evaluating the safety and efficacy of two commonly used tocolytic medications. The study highlights the need for careful consideration of potential risks and benefits, emphasizing the importance of individualised care and close monitoring to ensure the best possible outcomes for mothers and their babies. It's a reminder that the journey through preterm labor can be challenging, but with careful planning and a collaborative approach, we can find the most effective and safe path for navigating this delicate terrain.Date :
- Date Completed 1981-09-25
- Date Revised 2019-08-16
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.